scholarly article | Q13442814 |
P2093 | author name string | Jill Gilmour | |
Susan Allen | |||
Eric Hunter | |||
Ilene Brill | |||
William Kilembe | |||
Debby Basu | |||
Evonne Woodson | |||
Hope Olszewski | |||
P2860 | cites work | Short Communication: A Recombinant Variant with Increased Envelope Entry Efficiency Emerged During Early Infection of an HIV-1 Subtype C Dual Infected Rapid Progressor | Q36656789 |
Multiplexed highly-accurate DNA sequencing of closely-related HIV-1 variants using continuous long reads from single molecule, real-time sequencing | Q36676496 | ||
Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection | Q36763288 | ||
Dynamics of HIV type 1 recombination following superinfection | Q36842102 | ||
Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses | Q36994644 | ||
Transmission of HIV-1 in the face of neutralizing antibodies | Q37017806 | ||
Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection | Q37336404 | ||
HIV-1 Superinfection and its Implications for Vaccine Design | Q37807440 | ||
Sustained effect of couples' HIV counselling and testing on risk reduction among Zambian HIV serodiscordant couples. | Q39023570 | ||
Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response | Q40159859 | ||
Risk of heterosexual HIV transmission attributable to sexually transmitted infections and non-specific genital inflammation in Zambian discordant couples, 1994-2012. | Q40246165 | ||
HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies | Q47254280 | ||
Recombination following superinfection by HIV-1. | Q48967809 | ||
Superinfection Drives HIV Neutralizing Antibody Responses from Several B Cell Lineages that Contribute to a Polyclonal Repertoire. | Q52718554 | ||
HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth | Q57071746 | ||
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers | Q60908099 | ||
A patient with HIV-1 superinfection | Q74735775 | ||
HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response | Q21090490 | ||
Identifying HIV-1 dual infections | Q22241756 | ||
Dual HIV-1 infection associated with rapid disease progression | Q28247153 | ||
HIV superinfection | Q28259889 | ||
HIV drug resistance acquired through superinfection | Q28264308 | ||
Immune-correlates analysis of an HIV-1 vaccine efficacy trial | Q29617377 | ||
New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data | Q31160798 | ||
Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection | Q33504604 | ||
Comprehensive Characterization of Humoral Correlates of Human Immunodeficiency Virus 1 Superinfection Acquisition in High-risk Kenyan Women | Q33603702 | ||
Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates | Q33742529 | ||
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro | Q33853775 | ||
Low antibody-dependent cellular cytotoxicity responses in Zambians prior to HIV-1 intrasubtype C superinfection | Q34016675 | ||
Infection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virus | Q34120140 | ||
Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in Zambia | Q34327190 | ||
Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users | Q34343410 | ||
Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences | Q34577539 | ||
Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1 | Q34648079 | ||
HIV-1 superinfection | Q35581046 | ||
The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection | Q35686970 | ||
HIV-1 superinfection is associated with an accelerated viral load increase but has a limited impact on disease progression | Q35854639 | ||
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection | Q35857268 | ||
Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses | Q35950936 | ||
Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies | Q36262823 | ||
Contrasting antibody responses to intrasubtype superinfection with CRF02_AG. | Q36306344 | ||
HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection | Q36334990 | ||
Population genomics of intrapatient HIV-1 evolution | Q36479690 | ||
A pathway to HIV-1 neutralization breadth | Q36625139 | ||
P921 | main subject | Zambia | Q953 |
superinfection | Q1563808 | ||
HIV superinfection | Q4817339 | ||
P304 | page(s) | 11-19 | |
P577 | publication date | 2019-06-15 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | Reduced frequency of HIV superinfection in a high-risk cohort in Zambia | |
P478 | volume | 535 |
Search more.